āđāļāļĩāđāļĒāļ§āļāļąāļāļāļāļāļāļĩāđ
We're back with Chris Holsinger for part 2 of the TORS adventure
āļ āļēāļĐāļēāļāļąāļāļāļĪāļĐ
āļŠāļŦāļĢāļąāļāļāđāļĄāļĢāļīāļāļē
āļŠāļģāđāļāļēāļāļāļŠāļāļāļāļē 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
āļāđāļāļŦāļēāļāļāļāļāļĩāđāļāđāļēāļāļĄāļē
āļāđāļāļŦāļēāļāļāļāļāļĩāđāļāđāļēāļāļĄāļēāļāļāļ Deep Margin
āļāļāļāļāļ·āđāļāđ āđāļ PODCAST āļāļĩāđ
Nadeem Riaz directs the Precision Radiotherapy Initiative and leads a multidisciplinary research lab at the intersection of the DNA damage response and anti-tumor immunity. He talks us through his important paper examining mechanisms of resistance and some of the pitfalls of academia.
The Danish Head and Neck Cancer (DAHANCA) group was established in 1976 as a working group by the Danish Society for Head and Neck Oncology. Since it has gone from strength to strength and continues to pioneer cooperative group research on a national scale! Current head Jeppe Friborg talks us throuâĶ
Yungan Tao President-Elect GORTEC, and Radiation Oncologist in Head and Neck cancer at Institut Gustave-Roussy talks us through the NICOPOSTOP trial. Will risks diplomatic incidents and out European tour continues.
Pierre Blanchard, Professor at Gustave Roussy and Editor of Radiotherapy and Oncology 'the green journal' joins us to discuss his recent trial
āļāđāļāļŠāļāļ§āļāļŠāļīāļāļāļīāđ: āļāļāļāđāļāļŠāļāđāđāļĨāļ°āļāļēāļĢāđāļāđāļ§āļīāļĢāđāļāļāļĩāđāļāļąāļāļāļĒāļđāđāđāļāļŦāļāđāļēāļāļĩāđāļĄāļēāļāļēāļ Dr Ben O'Leary and Dr Will Ince āļāļķāđāļāđāļāđāļāļāļĢāļąāļāļĒāđāļŠāļīāļāļāļāļāđāļāđāļēāļāļāļāđāļĨāļ°āđāļĄāđāļĄāļĩāļŠāđāļ§āļāđāļāļĩāđāļĒāļ§āļāđāļāļāļŦāļĢāļ·āļāļĢāļąāļāļĢāļāļāđāļāļĒ Listen Notes, Inc.
āđāļāđāđāļ
āļāļāļāļāļļāļāļāļĩāđāļāđāļ§āļĒāļāļģāđāļŦāđāļāļēāļāļāđāļāļĄāļđāļĨāļāļāļāđāļāļŠāļāđāļĄāļĩāļāļ§āļēāļĄāļāļąāļāļŠāļĄāļąāļĒ
